Industry News

Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

MiddleBrook Pharmaceuticals, Inc. Secures $10 Million Revolving Line of Credit

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

Spectrum Pharmaceuticals, Inc. to Raise $21 Million from Institutional Investors at $7.1525 Per Share

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

Charles River Laboratories (Massachusetts) Announces RMS Succession Plan and Organizational Enhancements

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

Europe Approves AstraZeneca PLC Lung Cancer Drug

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

Biogen Idec, Inc. (Massachusetts) Gains Rights to Acorda Therapeutics’s MS Drug; to Get $110 Million Up Front

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

UCB Group and Biogen Idec, Inc. (Massachusetts) Discontinue Phase II Clinical Trial of CDP323

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

Novartis Corporation Sees FDA Decision on Menveo Early 2010 US After Regulator Seeks More Data on Meningitis Vaccine

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

U.S. FDA Casts Doubt on Lantus Cancer Link

Tuesday, June 30th, 2009
var addthis_pub"bdwyer";<img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...

ProCertus BioPharm, Inc. Raises $2.1 Million

Tuesday, June 30th, 2009
pehub.com -- ProCertus BioPharm Inc., a Madison, Wisc.-based developer of drugs to treat the side effects of chemotherapy and radiotherapy on cancer patients, has raised $2.1 million in new VC funding. Return backers include Novartis Venture Fund and Venture Investors LLC.